Corticosteroids for Acute Bacterial Meningitis

Annals of Emergency Medicine

Volumn 54, Issue 1, 2009, Pages 136-137

  Schultz, Brian R E ^a   Allen, Coburn H ^a   Kaplan, Sheldon L ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLYCEROL; HAEMOPHILUS INFLUENZAE VACCINE;

BACTERIAL MENINGITIS; CHILD CARE; DISEASE SEVERITY; HUMAN; LETTER; PNEUMOCOCCAL MENINGITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

ACUTE DISEASE; ADULT; CHILD; CHILD, PRESCHOOL; DEXAMETHASONE; GLUCOCORTICOIDS; HAEMOPHILUS INFLUENZAE; HEARING LOSS; HUMANS; INFANT; MENINGITIS, HAEMOPHILUS; YOUNG ADULT;

EID: 67149122046     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2008.11.030     Document Type: Letter

References (5)

1. Upadhye S. Corticosteroids for acute bacterial meningitis. Ann Emerg Med 53 (2008) 291-293
2. Arditi M., Mason Jr. E.O., Bradley J.S., et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 102 (1998) 1087-1097
3. Peltola H., Roine I., Fernández J., et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clinical Infectious Diseases 45 (2007) 1277-1286
4. Tunkel A.R., Hartman B.J., Kaplan S.L., et al. Practice guidelines for the management of bacterial meningitis. Clinical Infectious Diseases 39 (2004) 1267-1284
5. In: Pickering L.K., Baker C.J., Long S.S., and McMillan J.A. (Eds). Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. 530 (2006), American Academy of Pediatrics, Elk Grove Village, IL